Drugs / CH505 M5
last change Mar 2023 re-read 2 minutes ago

CH505 M5

Developed for
HIV infectious disease
Investigated by
National Institute of Allergy and Infectious Diseases (NIAID)

Trials 1 · a red edge is where a trial was stopped

201820192020202120222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT03220724 Aug 2017 → Mar 2023 HIV infectious disease National Institute of Allergy and Infectious Diseases (NIAID) Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as CH505 M5 ClinicalTrials.gov intervention name — accepted as the source's own label NCT03220724